Navigation Links Restructures purEffect(TM) Marketing Agreement with CK41

Company to take an active role in assisting CK41 in launching purEffectTM

SCOTTSDALE, Ariz., Feb. 12 /PRNewswire-FirstCall/ --, Inc. (OTC Bulletin Board: EFSF), an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products, today announced that it has restructured its Marketing Agreement with Charlston Kentrist 41 Direct, Inc. ("CK41"), the Company's joint venture marketing partner for purEffectTM, a four-step acne treatment system. believes that a more marketable financial arrangement and greater collaborative effort will enable CK41 to achieve its business financing goals and execute its product marketing plans. Under the terms of the restructuring, will transfer all of its rights to purEffectTM to CK41 for an approximate five percent (5%) equity stake in CK41 with three year warrant rights to purchase up to an additional five percent (5%) equity stake based on the current fully diluted ownership of CK41. Additionally, will receive a two percent (2%) royalty on worldwide purEffectTM adjusted gross sales. The restructured agreement also sets certain performance milestones for CK41 in the launch and marketing of purEffectTM. will have one seat on the CK41 board of directors.

Martin Schmieg, current president and CEO of Freedom2, Inc. and future Chairman and CEO of, commented, "Collectively, eFoodSafety and CK41 can position purEffectTM to reach its market potential in the all-in-one acne treatment solutions market. By pooling our financial and marketing resources, we can overcome the obstacles that have heretofore kept purEffectTM from the market. CK41's business plans are aggressive and rightly so in a market that demands performance and differentiation in order to gain market share. Both CK41 and eFoodSafety are committed to the success of purEffectTM. As such, we plan to do everything possible to help CK41 bring this product to market." will provide further details on the restructured Marketing Agreement on its monthly investor conference call, scheduled for Tuesday, February 17th at 4:30 p.m. Eastern time.

About, Inc.

eFoodSafety is an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products. The company's focus is on developing, licensing and commercialized healthcare products that address the health needs of consumers worldwide.

About CK41 Direct, Inc.

CK41 Direct, Inc. is a leading producer of direct response infomercial campaigns. Combining 50 years of expertise in network television and direct marketing know-how, the principals and directors of CK41 learned the direct response TV industry from the ground up. This experience has taught CK41 how both conventional and unconventional marketing strategies can excel a direct response television campaign.

Safe Harbor for Public Companies

Statements contained in this release that are not strictly historical are "forward-looking statements." Such forward-looking statements are sometimes identified by words such as "intends," "anticipates," "believes," "expects," and "hopes." The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include, but are not limited to, demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.

    Contacts:                         Investors:
    Blair Barnes, CFO                 Stephanie Carrington/Amy Glynn
    Freedom2, Inc.                    The Ruth Group
    Ph: 856-354-0707 ext. 201         646-536-7017/7023   

                                      Pat Arcand
                                      Arcand & Madison Public Relations
                                      Ph: 617-576-7777

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Engages IridiumGroup to Develop New Brand Identity to Match Future Company Direction
2. Selects Arcand & Madison as Public Relations Counsel and The Ruth Group as Investor Relations Counsel
3. NewCardio Restructures 2007 Financing, Receives $2.8 Million Additional Cash and Improves Capital Structure
4. VaxGen Restructures Following Termination of Proposed Merger
5. Pharmos Restructures Operations in Israel
6. Unbelievable Lack Of Marketing Knowledge Forces Doctors To Quit Practice.
7. Syndication Inc. Seeks Director of Marketing for Sy-Med Decompression Centers; BOD Considers Adding a Green Energy New Company Subsidiary to its Ranks
8. Medical Marketing Firm Builds Service Provider and Medical Practice Bottom Lines
9. Texcel Selects Tiziani Whitmyre for Public Relations, Internet Marketing Services
10. Mindset Marketing Solutions Partners with Platform-A, ValueClick Media, AdRX Media, Datran Media and Morefocus Media
11. ATi Tailored BI and Advanced Predictive Analytics Solutions Improve Marketing Response Rates
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... An inventor from Charlottesville, ... the womb. "My last baby had high blood pressure due to loud noises," she ... protect their babies from noise pollution as well as radio waves and microwaves." , ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... automated breast density assessment and enterprise analytics solutions, here at the 101st ... (South Hall booth #2377). Volpara’s quantitative breast imaging tools enable personalized measurements ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... – Kreithen”), one of the leading plastic surgery practices in Florida, is proud ... chosen to consult for surgical innovations giant Ethicon Inc., a Johnson & Johnson ...
(Date:11/30/2015)... Morton Grove, IL (PRWEB) , ... November 30, 2015 , ... ... milestone for an emerging pharmaceutical company. Because it is so important to this key ... titled “Success Factors in your IND Filing” on December 4th at 11am EST. , ...
(Date:11/30/2015)... ... 30, 2015 , ... Healthjump, Inc. announced that it has ... consulting, development and support company. The purchase will expand the capability to serve ... extend the services currently provided by Healthjump. , Through this purchase, ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... BOSTON , Nov. 30, 2015  Kevin ... of Sensium Healthcare, a global pioneer in wireless ... Boston, MA , Mr. Smith ... of Sensium,s global commercial strategy.  He will also ... universities, to build clinical evidence for SensiumVitals, the ...
(Date:11/30/2015)... , Nov. 30, 2015  The fee-for-service ... in U.S. medical imaging is on its ... accountable care payer-provider contracts are set to ... their wake, alter provider-vendor relationships. The shift ... push forward new purchasing frameworks in the ...
(Date:11/30/2015)... WOODCLIFF LAKE, N.J. and SAN ... Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) ... (FDA) has accepted for filing the New Drug Application ... approved, the extended release formulation will offer patients a ... ® ) is currently approved as ...
Breaking Medicine Technology: